(Circulation. 2004;109:e158-e160.)
© 2004 American Heart Association, Inc.
Cardiology Patient Page |
From Columbia University College of Physicians and Surgeons, New York, NY.
Correspondence to Lori Mosca, MD, PhD, Director, Preventive Cardiology, New York Presbyterian Hospital, 622 W 168th St, New York, NY 10032-3720. E-mail ljm10@columbia.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
A recent national study conducted by the American Heart Association showed that fewer than 50% of American women know that heart disease is their leading killer. The study included more than 1000 women from many different racial and ethnic backgrounds. More women in this study knew that heart disease was womens leading killer than in similar studies conducted in 1997 and 2000, but theres still a lot of room for improvement.
Cardiovascular diseasethe No. 1 cause of death in the United Statesclaims the lives of almost 500 000 women each year. Thats nearly one death every minute. Being aware of the risk of heart disease is important because its the first step in taking action to lower risk.
Because heart disease can often be prevented, the survey findings are an urgent call to action. The American Heart Association and 11 other leading national health organizations came together to develop comprehensive guidelines for heart disease prevention in women. They include a rating scale to express the strength of recommendations and the quality of research to support specific preventive therapies.
Each recommendation was categorized to help doctors and women decide which preventive therapies should or should not be used. A Class I category indicates that the type of therapy should be provided routinely. Class IIa indicates that most scientific evidence favors providing the type of therapy, whereas Class IIb indicates the usefulness of therapy is less well-established. Class III indicates that the type of therapy isnt useful and may be harmful.
Being
This article has been cited by other articles:
![]() |
S. J. Lewis, K. M. Fox, M. F. Bullano, S. Grandy, and for the SHIELD Study Group Knowledge of Heart Disease Risk Among SHIELD Respondents With Dyslipidemia Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF] |
||||
![]() |
J H Mieres Review of the American Heart Association's guidelines for cardiovascular disease prevention in women Heart, May 1, 2006; 92(suppl_3): iii10 - iii13. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Willerson March 16, 2004 Circulation, March 16, 2004; 109(10): 1195 - 1195. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |